These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
798 related articles for article (PubMed ID: 24007426)
1. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial. de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients. Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290 [TBL] [Abstract][Full Text] [Related]
3. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda. Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021 [TBL] [Abstract][Full Text] [Related]
6. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487 [TBL] [Abstract][Full Text] [Related]
7. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP; J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736 [TBL] [Abstract][Full Text] [Related]
10. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. Stevens SJ; Blank BS; Smits PH; Meenhorst PL; Middeldorp JM AIDS; 2002 May; 16(7):993-1001. PubMed ID: 11953465 [TBL] [Abstract][Full Text] [Related]
11. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. Stevens SJ; Pronk I; Middeldorp JM J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection. Friis AM; Akerlund B; Gyllensten K; Aleman A; Bratt G; Sandström E; Ernberg I Vaccine; 2012 Sep; 30(42):6093-8. PubMed ID: 22863659 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571 [TBL] [Abstract][Full Text] [Related]
14. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591 [TBL] [Abstract][Full Text] [Related]
15. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India. Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
17. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237 [TBL] [Abstract][Full Text] [Related]
18. The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection. Wang J; Ozzard A; Nathan M; Atkins M; Nelson M; Gazzard B; Bower M HIV Med; 2007 Jul; 8(5):306-11. PubMed ID: 17561877 [TBL] [Abstract][Full Text] [Related]
19. Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma. Leruez-Ville M; Seng R; Morand P; Boufassa F; Boue F; Deveau C; Rouzioux C; Goujard C; Seigneurin JM; Meyer L HIV Med; 2012 Sep; 13(8):479-87. PubMed ID: 22414000 [TBL] [Abstract][Full Text] [Related]
20. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]